My Two Cents: Listen to Joe Dolce and give weed a chance

Welcome to the 30th episode of “My Two Cents” with comedian Bill Engvall, the show designed to make you laugh and think! Scroll to the bottom to listen to this week’s episode.

Guest: Joe Dolce

Bill starts this episode talking about his rural upbringing, and about how closely it resembled a Norman Rockwell painting. In that context, Bill wonders if our kids are losing rights of passage — things like going fishing for the first time, getting your first ice cream cone with your granddad or the first time you created a swing out of something that was never meant to be used as a swing. Instead, Bill laments, our kids are very able to remember the first time you turned on an Xbox.

Later in the episode, Bill welcomes author Joe Dolce to the show to talk about what may be considered another right of passage: smoking marijuana. Having written the New York Times bestseller, Brave New Weed: Adventures Into the Uncharted World of Cannabis, Joe explains how he traveled around the world doing research for the book. Some of the findings: Ancient Egyptian women used to utilize marijuana to cope with morning sickness, Israel has done the vast majority of modern research on weed, Denver is producing some of the most high-octane marijuana known to man and weed has never been the direct cause of death of any one person in any country in the history of mankind.

And here’s the kicker: Bill also discusses the fact that he has used medicinal marijuana to deal with insomnia, that he wishes his father would use marijuana to help him cope with Parkinson’s disease and that he told his own son when he went off to college that he’d rather have him smoke a joint than do five shots of Jägermeister.

For a deeper look into the modern world of week, make sure to check out Joe’s website and follow him on Twitter.

Subscribe to Bill Engvall’s “My Two Cents” Podcast

Never miss an episode of the My Two Cents podcast! New episodes are released at BillEngvall.com/podcast each Wednesday. Follow the show on Facebook and Twitter, and subscribe on iTunes or PodcastOne.